Login

Navigating Industrial Evolution: Meeting Demand, Managing Costs, and Innovating in Critical Services 00:10:00

Share On Facebook Share On Twitter

Scott Salmirs, CEO of ABM Industries

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
TVA Board Meeting May Lead to Changes in Power Bill |Jeff Lyash, CEO ,Tennessee Valley Authority.
00:10:00
Positioning for Market Uncertainty: Strategies and Opportunities for 2023 | Seth Bernstein, CEO , AllianceBernstein AB .
00:00:00
Interview with EXPRO for ADIPEC 2023 | MIKE JORDAN, CEO, BOARD MEMBER, EXPRO GROUP HOLDINGS
00:10:00
Kuvera interviews Rahul Singh, Chief Investment Officer - Equities at Tata Asset Management, about Multi Cap Funds.|Gaurav Rastogi is the CEO of Kuvera
00:10:00
The explosion of fintech innovation and the mass migration to digital channels|Kabir Kumar,Director,Flourish Ventures
00:10:00
Empowering Digital Success: Tools and Insights for Wealth Management Strategies by Lee Francis at CREALOGIX | Oliver Weber, Chief Executive Officer of Crealogix Holding AG
00:10:00
wealth grow Investment opportunities|MARK HENTEMANN,CEO,Quantum Capital
00:10:00
Sayona Mining Advances Ossoe Lake Lithium Project at One-to-One Mainland Conference in Cape Town
00:00:00
Allergy Therapeutics to sniff out more M&A deals - Manuel Llobert, CEO, Allergy Therapeutics
00:10:00
Advantages of Large-Capacity Batteries for Underground Mining EVs
00:10:00
We aim to advance Catholic education in the Archdiocese of Philadelphia through innovative programs and projects initiated by Catholic schools, colleges, parishes, and religious and other Catholic-focused organizations. We provide financial support and as
00:10:00
committed to developing next-generation precision diagnostics and exosome solutions|Dr Gregory Rice,Chief Scientific Officer,Sienna Cancer Diagnostics Ltd

© 2017 - Neuhu+